Peter Boyle
Click Here to Download and Listen to The Cancer Letter’s Conversation with Peter Boyle
The International Prevention Research Institute has published “The State of Oncology 2013,” a report that highlights disparate cancer outcomes between higher- and lower-resource countries and proposes long-term recommendations.
By law, the Food and Drug Administration is required to determine whether a drug, device, biologic, or medical device is “safe and effective.” But the FDA determination does not control whether the Centers for Medicare & Medicaid Services will pay for it. To satisfy CMS, medical products and services must be “reasonable and necessary,” meaning...
As a radiation oncologist, I am struck by how often the decisive variable in lung cancer is not the sophistication of our therapy, but the timing of our encounter with the disease. The American Cancer Society projects 618,120 cancer deaths in the United States in 2025, with lung cancer remaining as the single largest contributor,...
